Implementing Hepatitis C treatment among HIV/HCV coinfected             INTERIM GUIDANCE FOR CONTINUING HIV PROGRAM SERVICE DELIVERY DURING COVID-19 PANDEMIC             National Integrated Biological and Behavioral Surveillance (IBBS) Survey among PWID            

National Centre for AIDS and STD Control (NCASC)

news and updates

December 17, 2021

Invitation for e-sealed Quotation for Procurement of STI/OI Drugs

04-IFB-NCASC-Q-SQ-01-2078-79
Date of Publication: 17th December, 2021

November 16, 2021

Invitation for Bids for Procurement of Anti-Retroviral Drugs

IFB:03, NCASC/G/ICB/01/2078-79
Date of Publication: 16th November, 2021

May 20, 2021

National Integrated Biological and Behavioral Surveillance (IBBS) Survey among PWID

NCASC conducted a nation-wide descriptive cross-sectional survey among people who inject drugs (PWID) in all Provinces of Nepal to generate both national and subnational HIV estimates

March 22, 2021

Implementing Hepatitis C treatment among HIV/HCV coinfected

On Chaitra 8, 2077 (March 21, 2021), NCASC implemented Hepatitis C (HCV) treatment among HIV/HCV coinfected from three ART centers of Kathmandu Valley.